Mindray's most Invested R&D Center Announced Construction


The construction of Mindray Wuhan Center, with a total investment of RMB 4.5 billion, was officially launched in Wuhan East Lake High-tech Development Zone (also known as Optics Valley) on June 20, 2020.

The project includes two major subprojects of Wuhan Research Institute and Manufacturing Center. The total net area is about 271 mu(18 hectacres)and the total construction area is about 620,000 square meters. Wuhan Research Institute and Wuhan Manufacturing Center will become Mindray’s second largest R&D center upon completion.

Message from Cheng Minghe, President of Mindray

Li Xiting, Chairman of Mindray, Cheng Minghe, President of Mindray and Li Zaiwen, Senior Vice President of Mindray, together with Vice President and General Manager of Wuhan Research Institute Huang Haitao, and Executive Vice President Liu Laiping attended the groundbreaking ceremony. Wang Zhonglin, party chief of Wuhan and the city’s mayor Zhou Xianwang were also present.

Construction is now underway

“The implementation of Mindray Wuhan Center is gathering the upstream and downstream industrial chains, helping Wuhan build a biomedical and medical device industry cluster, and accelerating the promotion of 'Big Health industry' development", said Mr. Zhou, the city's mayor.

Mindray Wuhan Research Institute is located in the High-tech Medical Devices Zone, Optics Valley Biolake. The institute comprises of five sections, biomaterial R&D center, surgical equipment R&D center, “Big Health” technology R&D center, global service support center and engineering technology transformation center. The new global R&D center of Mindray is expected to establish a 2,000 member’s staff in five years, including 1,200 high-end R&D personnel, to embark on a new journey with scientific exploration of Mindray.

Mindray is committed to putting healthcare within reach

Settled down in the Jiulong Industrial Base of Optics Valley Biolake, Mindray Wuhan Manufacturing Center is designed to become equipment manufacturing centers and engineering centers for orthopedic surgery (surgical robots), minimally invasive surgery and “Big Health”, reagent manufacturing center, biological raw material preparation center and supporting facilities. The industrial output value is expected to be no less than RMB 3 billion when the base is in full operation.

Upon completion, Mindray Wuhan Center will become a distinctive R&D, manufacturing and operation center of medical equipment system, biological raw materials, core components etc., in China. Taking independent innovation as the key driving force, Mindray will build a medical innovation highland to support the development of medical innovation technology.

Mindray respects your privacy. We use cookies for a variety of purposes, such as website functionality, improving your experience of our website, building integration with social media and helping target our advertising. By continuing your visit on our website, you are consenting to our use of cookies. However, you can change your cookie settings at any time.